Continuing evolution of migraine-specific therapies — targeting migraine with precision and persistence

Treatment options for migraine have expanded rapidly over the past few years. The latest success in a phase II trial of a new class of drugs for migraine holds the promise of another alternative, with important implications for our understanding of migraine and its clinical management.

Saved in:
Bibliographic Details
Published in:Nature reviews. Neurology 2024-11, Vol.20 (11), p.645-646
Main Authors: Mitsikostas, Dimos D., Rapoport, Alan
Format: Article
Language:English
Subjects:
692/617/375/1654
Clinical trials
Medicine
Medicine & Public Health
Migraine
Neurology
News & Views
news-and-views
Pathophysiology
Precision medicine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment options for migraine have expanded rapidly over the past few years. The latest success in a phase II trial of a new class of drugs for migraine holds the promise of another alternative, with important implications for our understanding of migraine and its clinical management.
ISSN:1759-4758
1759-4766
1759-4766
DOI:10.1038/s41582-024-01026-x